A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

NCT02079805 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension Complicated by Type 2 Diabetes Mellitus

Interventions

DRUG: Azilsartan
DRUG: Telmisartan

Sponsor

Takeda